Esophageal microbiota composition and outcome of esophageal cancer treatment: a systematic review
Open Access
- 11 November 2021
- journal article
- review article
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 35 (8)
Abstract
Background: The role of esophageal microbiota in esophageal cancer treatment is gaining renewed interest, largely driven by novel DNA-based microbiota analysis techniques. The aim of this systematic review is to provide an overview of current literature on the possible association between esophageal microbiota and outcome of esophageal cancer treatment, including tumor response to (neo)adjuvant chemo(radio)therapy, short-term surgery-related complications, and long-term oncological outcome. Methods: A systematic review of literature was performed, bibliographic databases were searched and relevant articles were selected by two independent researchers. The Newcastle-Ottawa scale was used to estimate the quality of included studies. Results: The search yielded 1303 articles, after selection and cross-referencing, five articles were included for qualitative synthesis and four studies were considered of good quality. Two articles addressed tumor response to neoadjuvant chemotherapy and described a correlation between high intratumoral Fusobacterium nucleatum levels and a poor response. One study assessed surgery-related complications, in which no direct association between esophageal microbiota and occurrence of complications was observed. Three studies described a correlation between shortened survival and high levels of intratumoral F. nucleatum, a low abundance of Proteobacteria and high abundances of Prevotella and Streptococcus species. Conclusions: Current evidence points towards an association between esophageal microbiota and outcome of esophageal cancer treatment and justifies further research. Whether screening of the individual esophageal microbiota can be used to identify and select patients with a predisposition for adverse outcome needs to be further investigated. This could lead to the development of microbiota-based interventions to optimize esophageal microbiota composition, thereby improving outcome of patients with esophageal cancer.Keywords
This publication has 45 references indexed in Scilit:
- Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: A prospective randomized controlled trialSurgery, 2012
- Intrathoracic Anastomotic Leakage and Mortality After Esophageal Cancer Resection: A Population-Based StudyAnnals of Surgical Oncology, 2011
- Exfoliated malignant cells at the anastomosis site in colon cancer surgery: the impact of surgical bowel occlusion and intraluminal cleaningInternational Journal of Colorectal Disease, 2011
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementJournal of Clinical Epidemiology, 2009
- Inflammation and Intestinal Metaplasia of the Distal Esophagus Are Associated With Alterations in the MicrobiomeGastroenterology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Efficacy of enteral decontamination in the prevention of anastomotic dehiscence and pulmonary infection in esophagogastric surgeryDiseases of the Esophagus, 2008
- Microbial Colonization of the Upper Gastrointestinal Tract in Patients with Barrett's EsophagusClinical Infectious Diseases, 2007
- OESOPHAGEAL MICROBIAL FLORA IN CARCINOMA OF THE OESOPHAGUSAnz Journal of Surgery, 1981
- Protection of Colonic Anastomoses with AntibioticsAnnals of Surgery, 1956